NCT03260517View on ClinicalTrials.gov

The PREVAIL Study

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

January 29, 2019

Study Completion Date

August 1, 2019

Conditions
In-stent RestenosisIschemic Heart DiseaseCoronary Artery Disease
Interventions
DEVICE

Medtronic Coronary Drug-Coated Balloon Catheter

Medtronic Paclitaxel Coronary Drug-Coated Balloon Percutaneous transluminal coronary angioplasty

Trial Locations (10)

2020

ZNA Middelheim, Antwerp

3600

Ziekenhuis Oost-Limburg, Genk

4000

CHU Liege, Liège

20097

IRCCS Policlinico San Donato, Milan

20132

Ospedale San Raffaele, Milan

1091 AC

Onze Lieve Vrouwe Gasthuis, Amsterdam

3435 CM

St. Antonius Ziekenhuis, Nieuwegein

2545 AA

Haga Ziekenhuis locatie Leyweg, The Hague

3584 CX

Universitair Medisch Centrum Utrecht, Utrecht

8025 AB

Isala Klinieken, Zwolle

Sponsors

Lead Sponsor

Medtronic Vascular
All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT03260517 - The PREVAIL Study | Biotech Hunter | Biotech Hunter